Evidence map›Paper›PMID 42893276›Full record

ArticleBioinformatics advances2026

PerSeqPIPE: Nextflow workflow for per-sequence analysis of small RNA-sequencing data.

Karolína Trachtová, Dagmar Al Tukmachi, Vojtěch Bystrý, Ondřej Slabý

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karolína TrachtováCentral European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic.ORCID https://orcid.org/0009-0006-1835-8862
Dagmar Al TukmachiCentral European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic.
Vojtěch BystrýCentral European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic.
Ondřej SlabýCentral European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-8450-0584

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: Small RNA sequencing enables high-throughput profiling of diverse small non-coding RNAs, but their complex biology creates substantial bioinformatic challenges. Conventional gene-centric pipelines often discard multi-mapping reads or impose arbitrary feature assignments, leading to biased quantification results. We present PerSeqPIPE, a modular, fully containerized Nextflow pipeline implementing a sequence-centric approach that quantifies each unique read sequence and annotates it with all compatible genomic and transcriptomic features. This preserves biologically relevant signals and enables broad small non-coding RNA profiling. PerSeqPIPE integrates harmonized reference resources for multiple small non-coding RNA classes and supports reproducible execution using Docker and Apptainer. The accompanying Streamlit-based PerSeqPIPE VIZ application enables interactive exploration, filtering, visualization, and differential expression analysis. Application to a published extracellular vesicle dataset revealed isomiR diversity and multi-mapped sncRNAs that were obscured by conventional approaches. Together, PerSeqPIPE and PerSeqPIPE VIZ provide an open, scalable, and transparent framework for small RNA-seq analysis. Availability and implementation: PerSeqPIPE is freely available at https://github.com/ktrachtova/perseqpipe and PerSeqPIPE VIZ at https://github.com/ktrachtova/perseqpipe_viz. PerSeqPIPE is implemented in Nextflow, Python, Bash, and R; PerSeqPIPE VIZ is a Streamlit app. Both are compatible with macOS and Linux operating systems.

Identifiers

PMID42893276
PMCPMC13676317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.